Virios therapeutics to present at the virtual h.c. wainwright bioconnect conference

Atlanta--(business wire)---- $viri #biotech--virios therapeutics, inc. (nasdaq: viri), a development-stage biotechnology company focused on advancing novel antiviral therapies to treat debilitating chronic diseases, including fibromyalgia, announced today that greg duncan, chairman and chief executive officer, will present a company overview at the h.c. wainwright bioconnect conference, which is taking place virtually january 10 - 13, 2022. the presentation will focus on the role of activated viruses triggering a
VIRI Ratings Summary
VIRI Quant Ranking